Company intelligence / Profile preview
Telomir Pharmaceuticals, Inc.
Miami, Florida, United Statestelomirpharma.com ↗
- Ownership
- Public · TELO
- Development stage
- Preclinical
01
Overview
Telomir-1 has demonstrated reversal of biological clock in preclinical models, improving lifespan and health span, enhancing mitochondrial energy production, reducing oxidative stress, and correcting calcium signaling pathways. Telomir-Ag2 has shown broad-spectrum antimicrobial activity against drug-resistant pathogens including MARSA.
- Therapeutic areas
- PsychiatryOphthalmologyEndocrinologyOtherOncologyRare DiseasesNeurologyInfectious Diseases
- Modalities
- Small moleculesStabilized Silver(II) complex
- Industry
- Biotech
02
Drug pipeline
4 assets3 more assets in the full pipeline.
03
Financials
- Market cap
- $57.4M
- Total revenue
- $0
- Enterprise value
- $52.3M
Beyond the preview
Go deeper on Telomir Pharmaceuticals, Inc..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Telomir Pharmaceuticals, Inc..